Novel quinoline derivatives containing substituted oxadiazole as an anticancer agent
IN604936BActive Publication Date: 2026-10-05ATMIYA UNIV +2
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- IN202321086930
- Authority / Receiving Office
- IN · IN
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2023-12-19
- Publication Date
- 2026-10-05
Abstract
ABSTRACT Novel quinoline derivatives containing substituted oxadiazole as an anticancer agent The present invention relates to the synthesis of novel quinoline derivatives containing substituted oxadiazole and evaluation of their anti-cancer activities. The quinolone based 1,2,4-oxadiazol-5(4H)-one ring (6a to 6p) derivatives and 1,2,4-oxadiazole-5(4H)-thione ring (7a to 7p) derivatives are synthesized using the formula (I). The anti-cancer activities of synthesized hybrid molecules show promising anticancer activity on Central Nervous System Cancer Cell Line: SNB-75, Melanoma Cell Line: MDA-MB 435 & SK-MEL 5, and in Breast Cancer Cell Line: T- 47D & MDA-MB-468 cell-lines. (I)
Need to check novelty before this filing date? Find Prior Art
